Tolerogenic Immunomodulation by PEGylated Antigenic Peptides

Current treatments for autoimmune disorders rely on non-specific immunomodulatory and global immunosuppressive drugs, which show a variable degree of efficiency and are often accompanied by side effects. In contrast, strategies aiming at inducing antigen-specific tolerance promise an exclusive speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeil, Jennifer, Simonetti, Mario, Lauer, Uta, Volkmer, Rudolf, von Thülen, Bianca, Durek, Pawel, Krähmer, Ralf, Leenders, Frank, Hamann, Alf, Hoffmann, Ute
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581722/
https://www.ncbi.nlm.nih.gov/pubmed/33162973
http://dx.doi.org/10.3389/fimmu.2020.529035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581722/
https://www.ncbi.nlm.nih.gov/pubmed/33162973
http://dx.doi.org/10.3389/fimmu.2020.529035

Ejemplares similares